The Bulletin
Men's Weekly


.

HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals to Showcase Ongoing Parkinson's Disease Program at the 7th Annual Sachs Associates Neuroscience Innovation Forum

  • Written by PR Newswire
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals to Showcase Ongoing Parkinson's Disease Program at the 7th Annual Sachs Associates Neuroscience Innovation Forum

ROCKVILLE, Md., Dec. 20, 2023 /PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS), Daewoong Pharmaceutical (KRX: 069620.KS), and NurrOn Pharmaceuticals announced their participation in the 7th Annual Sachs Associates Neuroscience Innovation Forum. The event is scheduled to take place on January 7th, 2024, at the historic Marines' Memorial Club in San...

The Bulletin Magazine

Understanding Life Insurance in Australia

How Headless CMS Supports High-Traffic Event-Driven Websites

Why Structured Content Is the Core Advantage of Headless CMS

Services Lawyers in Brisbane Can Provide for Growing Businesses

What to Expect When Working with Lawyers in Sydney for the First Time

Dentist Bundoora Providing Trusted Local Dental Care for Every Stage of Life

CoolSculpting Melbourne for Non-Invasive Fat Reduction and Body Contouring

The Gold Standard: A Definitive Guide to Australian Oral Care

Self Managed Super Fund Setup for Greater Control and Smarter Retirement Planning

Designing an Outdoor Space You’ll Actually Use

7 Best New Home Inspectors in Melbourne (2026 Guide)

Exploring Australia’s Best Food Scenes Outside Major Cities